Aurobindo Pharma Limited (NSE: AUROPHARMA)
India flag India · Delayed Price · Currency is INR
1,465.95
-43.35 (-2.87%)
Oct 10, 2024, 3:30 PM IST

Aurobindo Pharma Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Jun '24 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2019 - 2015
Net Income
-31,73019,27526,48253,34828,451
Upgrade
Depreciation & Amortization
-14,39411,96210,83310,5549,632
Upgrade
Other Amortization
-525.2413.1432.4-35
Upgrade
Loss (Gain) From Sale of Assets
--234.9-132.31,558-31,084370.4
Upgrade
Asset Writedown & Restructuring Costs
-623.7309.9-396.34,349-
Upgrade
Loss (Gain) From Sale of Investments
--1--264.3--
Upgrade
Loss (Gain) on Equity Investments
-171.5116.7312.5553.6151.7
Upgrade
Provision & Write-off of Bad Debts
-232.8524.5-61.1-291.2685.3
Upgrade
Other Operating Activities
--6,3452,348-4,3096,5271,408
Upgrade
Change in Accounts Receivable
--2,642-4,321-4,1087,440-6,561
Upgrade
Change in Inventory
--13,037-9,26714,975-16,217-5,270
Upgrade
Change in Accounts Payable
-5,8287,0771,1071,2652,959
Upgrade
Change in Other Net Operating Assets
--6,900-4,4383,605-3,15511,951
Upgrade
Operating Cash Flow
-24,34523,86850,16533,29143,813
Upgrade
Operating Cash Flow Growth
-2.00%-52.42%50.69%-24.02%165.38%
Upgrade
Capital Expenditures
--27,803-24,038-20,529-14,379-13,828
Upgrade
Sale of Property, Plant & Equipment
-602.8110.93,809481.7190
Upgrade
Cash Acquisitions
---1,970-5,814-2,742103.5
Upgrade
Divestitures
---43.231,739-
Upgrade
Sale (Purchase) of Intangibles
--7,812-3,166-6,517-4,359-483.4
Upgrade
Investment in Securities
-1,5354,428-3,361-4,674-1,877
Upgrade
Other Investing Activities
--9,082-15,142252.6-79.6217.8
Upgrade
Investing Cash Flow
--42,560-39,778-32,1165,987-15,676
Upgrade
Short-Term Debt Issued
--20,697---
Upgrade
Long-Term Debt Issued
-15,6323,936827.31,770-
Upgrade
Total Debt Issued
-15,63224,633827.31,770-
Upgrade
Short-Term Debt Repaid
--847.6--26,367-6,678-13,130
Upgrade
Long-Term Debt Repaid
--1,638-981.2-1,331-5,904-3,194
Upgrade
Total Debt Repaid
--2,485-981.2-27,698-12,583-16,324
Upgrade
Net Debt Issued (Repaid)
-13,14723,651-26,871-10,813-16,324
Upgrade
Issuance of Common Stock
-----1.9
Upgrade
Common Dividends Paid
--2,636-4,395-2,637-2,343-1,756
Upgrade
Other Financing Activities
--2,507-1,112-185-493.5-1,394
Upgrade
Financing Cash Flow
-8,00418,144-29,693-13,649-19,472
Upgrade
Foreign Exchange Rate Adjustments
-141.7-0.62-21.247.8
Upgrade
Miscellaneous Cash Flow Adjustments
--64.1-32.5224.1-
Upgrade
Net Cash Flow
--10,0682,298-11,67425,8318,712
Upgrade
Free Cash Flow
--3,458-170.529,63618,91129,985
Upgrade
Free Cash Flow Growth
---56.71%-36.93%1230.96%
Upgrade
Free Cash Flow Margin
--1.19%-0.07%12.63%7.63%12.98%
Upgrade
Free Cash Flow Per Share
--5.90-0.2950.5832.2751.17
Upgrade
Cash Interest Paid
-2,5071,112185493.51,266
Upgrade
Cash Income Tax Paid
-17,6667,17212,58212,8537,736
Upgrade
Levered Free Cash Flow
--12,590-4,80312,12913,66221,013
Upgrade
Unlevered Free Cash Flow
--10,914-3,99712,35914,03522,807
Upgrade
Change in Net Working Capital
-17,7544,810-7,4755,702-2,825
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.